ARCHIVES

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

This article is from The Cancer Letter archive.

Vol. 38 No. 08 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

Pesticides Increase Leukemia Risk, USA Investigations Report

July 17, 1987

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979